White paper

Precision medicine in cell and gene therapy: Building integrated clinical strategies for complex modalities

Cell and gene therapies are transforming the possibilities of precision medicine while introducing new complexities across clinical development. This paper explores the structural, operational and regulatory challenges that shape CGT programs, from patient identification and trial design to long-term follow-up and evidence generation. It also outlines emerging approaches to building more integrated, flexible clinical strategies that can adapt to small patient populations, evolving requirements and global variability.

Download the paper to gain practical insights into designing and executing clinical programs that are better aligned with the unique demands of these advanced therapies.